Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company in California that focuses developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. Founded in 2016 in Westlake Village, California, United States by Bhaskar Chaudhuri, Arcutis Biotherapeutics is a company that focuses on treatments on the fields of inflammation and immunology. It discovers therapeutic molecules that act on validated physiologic targets to treat dermatological diseases and disorders. The company is made up of a team that has developed more than 50 FDA-approved products.
The company focuses on dermatological products that target diseases such as plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, alopecia areata and seborrheic dermatitis. As of 2020, the company is currently developing four compounds: topical roflumilast cream (ARQ-151), topical roflumilast foam (ARQ-154), ARQ-252 and ARQ-255.